HomePCSA

PCSA

Breaking News

Processa Pharmaceuticals Announces Successful Completion of Phase 1b Safety Evaluation of NGC-Cap in Patients with Advanced Cancer Resulting in Recommended Phase 2 Doses

editor - January 25, 2024

No posts to display

Most Read

Expected US Company Earnings on Wednesday, May 15th, 2024

May 16, 2024

SEEL announced stock split 1-8

May 16, 2024

US Companies Moving the Markets, Morning edition Wed, May 15, 2024 as of 10.00 am ET

May 15, 2024

Expected US Company Earnings on Wednesday, May 15th, 2024

May 15, 2024